Prothena Corp. Plc (PRTA)
10.03
+0.31
(+3.19%)
USD |
NASDAQ |
Apr 01, 16:00
10.01
-0.02
(-0.20%)
Pre-Market: 20:00
Prothena EPS Diluted (Quarterly) : -0.401 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 0.9419 |
| Jazz Pharmaceuticals Plc | 3.207 |
| Amarin Corp. Plc | -0.0587 |
| Iterum Therapeutics Plc | -0.196 |
| GH Research Plc | -0.2279 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.59M |
| Revenue (Quarterly) | 0.021M |
| Total Expenses (Quarterly) | 21.61M |
| Enterprise Value | 240.79M |
| Gross Profit Margin (Quarterly) | -4.39K% |
| Profit Margin (Quarterly) | -102.8K% |
| Earnings Yield | -43.90% |
| Normalized Earnings Yield | -40.11 |